الصفحة الرئيسية>>Lenalidomide-C4-NH2 hydrochloride

Lenalidomide-C4-NH2 hydrochloride (Synonyms: Cereblon ligand 1 hydrochloride; E3 ligase Ligand-Linker Conjugates 32 hydrochloride)

رقم الكتالوجGC60984

هيدروكلوريد Lenalidomide-C4-NH2 هو يجند Cereblon القائم على Lenalidomide المستخدم في توظيف بروتين CRBNيمكن توصيل هيدروكلوريد ليناليدوميد- C4-NH2 بالرابط الخاص بالبروتين بواسطة رابط لتشكيل PROTAC (المركب 24) ، الذي يحتوي على IC50s من 0.98 نانومتر و 13.7 نانومتر في تثبيط RS4 ؛ 11 و MOLM-13 نمو خطوط خلايا سرطان الدم الحاد ، على التوالى.

Products are for research use only. Not for human use. We do not sell to patients.

Lenalidomide-C4-NH2 hydrochloride التركيب الكيميائي

الحجم السعر المخزون الكميّة
100mg
417٫00
متوفر
500mg
1344٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Lenalidomide-C4-NH2 hydrochloride is the Lenalidomide-based Cereblon ligand used in the recruitment of CRBN protein. Lenalidomide-C4-NH2 hydrochloride can be connected to the ligand for protein by a linker to form PROTAC (Compound 24), which has IC50s of 0.98 nM and 13.7 nM in inhibition of RS4;11 and MOLM-13 acute leukemia cell lines growth, respectively[1].

[1]. Zhou B, et al. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression. J Med Chem. 2018 Jan 25;61(2):462-481.

مراجعات

Review for Lenalidomide-C4-NH2 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Lenalidomide-C4-NH2 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.